Froimson Mark

Director · PCRX

As of 2026-09-16, Froimson Mark has 5 Form 4 transactions on record across 1 company — 3 in the trailing 12 months.

Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.

Reconstructed holdings

Direct: $271KIndirect: $0$271Kas of 2026-09-16
  • Direct $271K
  • Indirect $0
PCRXdirect10,891 sh$271K

Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.

Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.

Trades by company

PCRX · 5 trades
2026-06-10: Award / grant, 6,405 sh ($0)2026-06-10: Award / grant, 10,891 sh ($0)2026-03-17: Sale, 500 sh ($11K)2025-06-11: Award / grant, 6,163 sh ($0)2025-06-11: Award / grant, 11,279 sh ($0)

Filing ledger

DateCompanyActionShares @ priceValueOwnership ΔOwned afterFiling
2026-03-17PCRXSale500 @ $21.81$11K−2.4% of holding20,136Form 4
4 award / exercise / gift records — not counted as purchases
DateCompanyActionSharesOwned afterFiling
2026-06-10PCRXAward / grant6,40526,541Form 4
2026-06-10PCRXAward / grant10,89110,891Form 4
2025-06-11PCRXAward / grant6,16320,636Form 4
2025-06-11PCRXAward / grant11,27911,279Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.